Publikace
- Population pharmacokinetics and covariate-based dosing individualization of voriconazole in lung transplant recipients2024 | 2. lékařská fakulta, 1. lékařská fakulta
- Effect of SARS-CoV-2 infection on anti-HLA antibodies and de novo donor specific antibodies incidence in lung transplant recipients2023 | 2. lékařská fakulta, 1. lékařská fakulta, Ústřední knihovna
- Defining a NK cell-enriched molecular rejection-like state in lung transplant transbronchial biopsies2023 | 2. lékařská fakulta, Ústřední knihovna
- Dosing Optimization of Posaconazole in Lung-Transplant Recipients Based on Population Pharmacokinetic Model2023 | 2. lékařská fakulta, 1. lékařská fakulta
- Demonstration of the Rationale for Therapeutic Drug Monitoring of Isavuconazole: A Case Report with a Lung Transplant Recipient2023 | 2. lékařská fakulta, 1. lékařská fakulta
- A patient with pulmonary hypertension waiting for donor lungs during the pandemic: 194 days on extracorporeal life support including 143 days on pulmonary artery to left atrium shunt2022 | 2. lékařská fakulta, 1. lékařská fakulta, Ústřední knihovna
- Transcripts associated with chronic lung allograft dysfunction in transbronchial biopsies of lung transplants2022 | 2. lékařská fakulta, Ústřední knihovna
- Impaired Humoral Response to Third Dose of BNT162b2 mRNA COVID-19 Vaccine Despite Detectable Spike Protein-specific T cells in Lung Transplant Recipients2022 | 2. lékařská fakulta, 1. lékařská fakulta
- Ganciclovir Pharmacokinetics and Individualized Dosing Based on Covariate in Lung Transplant Recipients2022 | 2. lékařská fakulta, 1. lékařská fakulta
- Significance of plasma fibrinogen and malondialdehyde in the post-inflammatory period in patients with cystic fibrosis2022 | 2. lékařská fakulta, 1. lékařská fakulta
Loading network view...